Pharmeca.cz

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Menarini International Operations Luxembourg S.A., against the decision of the State Institute for Drug Control from 26. 5. 2017, under the no. SUKLS101151/2017 - I. Under article 90 paragraph 4 in connection with article 66 paragraph 1 letter f) of the Administrative Code the operation part 5, 6, 11, 12, 13, 15, 16, 17, 18, 24, 25, 33, 34, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 64, 74, 86, 87, 88, 89, 90, 91, 92, 100, 102, 110, 111, 112, 113, 114, 115, 116, 117 and 118 of the decision under appeal is dismissed and the proceedings are terminated.

II. Under article 90 paragraph 5 of the Administrative Code the appeal is dismissed and the rest of the decision under appeal is upheld.

More information: MZCR.cz (czech version only)

 

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Pfizer Limited, against the decision of the State Institute for Drug Control from 21. 4. 2017, under the no. SUKLS101731/2014 - 

The appeal is dismissed and the decision under appeal is upheld.

More information: MZCR.cz (czech version only)

 

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Zentiva, k.s against the decision of the State Institute for Drug Control from 8. 9. 2017, under the no. SUKLS53158/2017. The appeal is dismissed and the decision under appeal is upheld.

More information: MZCR.cz (czech version only)

 

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant AOP Orphan Pharmaceuticals AG, against the decision of the State Institute for Drug Control from 13. 1. 2020, under the no. SUKLS7646/2020 - The appeal is dismissed and the decision under appeal is upheld.

More information: MZCR.cz (czech version only)

 

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Merck Sharp & Dohme B.V., against the decision of the State Institute for Drug Control from 31. 10. 2019 under the no. SUKLS215540/2019 - 

The appeal is dismissed and the decision under appeal is upheld.

More information: MZCR.cz (czech version only)

 

Acting in compliance with Section 39n(1) of Act No. 48/1997 Coll., on Public Health Insurance, as amended (“Act”), the State Institute for Drug Control publishes the List of Prices and Reimbursements for Medicinal Products and Foods for Special Medicinal Purposes (“List”).

 

Více na: EN SUKL - List of reimbursed medicinal products

 

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Svaz zdravotních pojišťoven, Boehringer Ingelheim International GmbH, BAYER AG, Bristol-Myers Squibb/Pfizer EEIG against the decision of the State Institute for Drug Control from 30. 9. 2019, under the no. SUKLS215786/2013 - I. Under article 90 paragraph 1 letter b) ot the Administrative Code the operative part 2, 3, 4b), 5b), 6b), 12b), 13b), 14b), 15, 16, 17, 18, 19, 20, 21 and 22 of the decision under appeal is reversed and the issue is referred back to the State Institute for Drug Control for reappraisal. II. Under article 90 paragraph 4 in conncetion with article 66 paragraph 2 of the Administrative Code the operative part 10 of the decision under appeal is dismissed and the proceedings are terminated. III. Under article 90 paragraph 5 of the Administrative Code the appeal is dismissed and the rest of the decision under appeal is upheld.

More information: MZCR.cz (czech version only)

 

Acting in compliance with Section 39n(1) of Act No. 48/1997 Coll., on Public Health Insurance, as amended (“Act”), the State Institute for Drug Control publishes the List of Prices and Reimbursements for Medicinal Products and Foods for Special Medicinal Purposes (“List”).

 

Více na: EN SUKL - List of reimbursed medicinal products